Hide Board Information

Show Board Information

Clover Health Investments Corp. CLOV

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/17/2024 11:40:42 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 5

Clover Health Investments Corp. (NASDAQ: CLOV) Stock Message Board

1. CLOV Company Profile

    

2. CLOV Time & Sales

    

3. CLOV Recent News

    

4. CLOV Filings

    

5. CLOV Financials

    

6. CLOV Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

10	$CLOV has built a scaleable and profitable	Coachplank	08/17/2024 11:40:42 AM
9	CLOV 21% v46,8M c2.45 f470M preMH2.67	znewcar1	02/24/2022 6:21:44 PM
8	2.7% H8.28 S@8? hate these charts a) recent IPO	znewcar1	10/11/2021 5:28:39 PM
7	CLOV 22% v171M c10.80 f410M	znewcar1	09/07/2021 4:15:04 PM
6	CLOV - Shorts Are In Trouble	J L	06/30/2021 9:52:55 AM
5	WALLSTREETBETS RUNDOWN - CLOV Stock, TSLA Stock,	J L	06/24/2021 3:25:41 AM
4	CLOV 12% v154M c12.63 f408M H13.95	znewcar1	06/22/2021 11:38:45 PM
3	CLOV 85% v717M c22.15 f408M H24.93 S16.9 strong	znewcar1	06/08/2021 4:06:45 PM
2	CLOV 32% v115M c11.92 f408M H12 strong aft gapNgo	znewcar1	06/07/2021 4:17:07 PM
1	CLOV 20% v76,9M c8.85 f406M H9.23 BO7.25 in the	znewcar1	04/08/2021 11:51:32 PM

Recent Articles

• XenDex $XDX Presale: 20% Sold in a Day, Analysts Bullish!
• Skyworks Solutions Investors: A Guide to Joining the Class Action
• Baltimore Author Explores Identity in New Space Opera Novel
• Unlocking Innovation: ONO PHARMA's 2025 Golden Ticket Contest
• Chery's HIMLA Series Launch Transforms Pickup Landscape
• Kaldvik AS Achieves Major Milestone with New Share Issuance
• Unlocking Crypto Futures: Explore BexBack's Exciting Offers!
• Understanding China's Economic Direction from Recent Leadership Talks
• Celebrating the Golden Era of Chinese Cinema in 2025
• Yiwugo App Experiences International Success in Sales Growth
• Investors Alert: Join the Geron Corporation Class Action Now
• Exciting Updates on TARA-002's Efficacy Against NMIBC
• ARBOR Technology Highlights Cutting-Edge Automation Innovations
• Class Action Lawsuit Opportunity for Geron Corporation Investors
• Mytheresa and Pucci Unveil Unique Capsule Collection in Style
• Syntech Partners with Meta to Innovate XR Accessory Solutions
• Investors of Ultra Clean Holdings, Inc. Can Join Class Action Now
• Chery Introduces the HIMLA Series, Transforming Pickup Dynamics
• Investors Unite Against Treace Medical Concepts Securities Fraud
• Important Annual Meeting of P/F Atlantic Petroleum Scheduled
• Meizu Impresses with AI Innovations at Global Mobility Expo
• EHR Apps Market Driven by Innovations, Expected to Reach $1.66B
• Exploring Next-Generation Sequencing Data Analysis Growth
• Transforming Retail Financing with LendPro and SPLICE Partnership
• Final Countdown: Join the Exciting $XPL Presale Now!
• Exploring Spark Retainers & BiteSync Class II Corrector Launch
• XenDex Sees Surge in Community Growth and Presale Demand
• Understanding Key Economic Strategies from China's Leadership Meeting
• Financière de Tubize Announces Annual Dividend Distribution
• Celebrating Cinema at the 20th China Film Huabiao Awards
• Movado Group Faces SEC Scrutiny, Rosen Law Firm Steps In
• Experience the Thrill of Japan Open Poker Tour 2025
• A.I.S. Resources Completes Successful Private Placement Initiative
• Ready Capital Shareholder Legal Updates: Know Your Rights
• Investors Urged to Act: Lawsuits Filed Against e.l.f. Beauty
• Understanding Your Rights as a Bancorp Investor in Legal Matters
• Important Update for Viatris Investors: Legal Action Insights
• AppLovin Investors Reminded of Important Class Action Deadline
• Investors Have a Deadline to Join NET Power Class Action
• Fluence Energy Class Action Update: Important Deadline Approaches
• AppLovin Corporation Faces Shareholder Class Action Opportunities
• Formosa Pharmaceuticals Partners With Saval For New Eye Treatment
• Antengene Showcases Innovative Therapeutics at AACR Event
• 51Talk Online Education Group Releases Key Annual Report for 2024
• Skye Bioscience Unveils Stock Option Grant for New Employee
• Innovent Celebrates NMPA Approval of Limertinib for Lung Cancer Treatment
• Willow Biosciences Reveals Results from Recent Shareholder Meeting
• Investigation into Bitfarms Ltd: What Investors Should Know
• Investigation into HealthEquity, Inc. Sparks Investor Interest
• Creative Science Expands Horizons with Astaria Global Acquisition